Atlas Trials

DCE-MRI PET Bevacizumab Study in Rectal Cancer

Clinical trial NCT01426074 · WITHDRAWN

Trial details

NCT number
NCT01426074
Sponsor
Abramson Cancer Center at Penn Medicine
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal Cancer Patients
Start date
2011-08-01
Primary completion
2014-06-11
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.